Sarepta Therapeutics · 6 hours ago
Nonclinical Research Intern
Columbus, OH
Internship
Onsite
Intern
$21/hr - $26/hrSarepta Therapeutics is at the forefront of genetic medicine, particularly in Duchenne muscular dystrophy, and is seeking a Nonclinical Research Intern. The intern will support molecular assays, data analysis, and model development to accelerate ongoing research timelines and contribute to innovative therapies.
BiotechnologyGeneticsHealth CareTherapeutics
No H1B
Responsibilities
Explore, establish, and maintain 3D liver models or transwell culture systems that more accurately represent physiological liver environments
Perform AAV transduction experiments under both control and steatosis conditions to evaluate liver injury phenotypes
Conduct molecular assays—including ddPCR, RT‑ddPCR, and ELISA—to quantify relevant injury or mechanistic markers
Contribute to assay development and optimization for mechanistic endpoints such as:
Steatosis markers
Fibrosis markers
Oxidative stress indicators
Apoptosis markers
Assist with experimental planning, sample processing, data organization, and preliminary data interpretation
Summarize experimental findings in a scientific presentation delivered to the team at the end of the internship
Maintain accurate and detailed electronic lab records in accordance with scientific and organizational standards
Qualification
Required
Currently pursuing a bachelor's degree, master's degree in biology, Molecular Biology, Biochemistry, Biomedical Engineering, Pharmacology, or a related scientific discipline
Strong attention to detail and commitment to producing high‑quality, reproducible data
Ability to follow scientific protocols, ask thoughtful questions, and adapt to new experimental techniques
Strong communication, organization, and collaboration skills
Interest in therapeutic development, AAV biology, or toxicology research
Preferred
Prior laboratory experience in cell culture or molecular biology preferred (coursework or lab rotations acceptable)
Familiarity with assays such as PCR, ELISA, or cell‑based assays is a plus
Benefits
Sarepta Therapeutics offers a competitive compensation and benefit package.
Company
Sarepta Therapeutics
Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.
Founded in 1980
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.88BKey Investors
Michael Andrew ChambersPharmakon AdvisorsMidCap Financial
2025-12-11Post Ipo Debt· $291.4M
2025-08-21Post Ipo Equity
2025-08-21Post Ipo Debt· $602M
Leadership Team
Ian Estepan
Executive Vice President, Chief Financial Officer
K
Kathy Behrens Wilsey
Director
Recent News
2026-01-24
Genetic Engineering News
2026-01-23
Company data provided by crunchbase